You are here: Home » News-CM » Companies » Results
Business Standard

Combat Drugs reports consolidated net profit of Rs 0.08 crore in the June 2019 quarter

Capital Market 

Sales decline 70.37% to Rs 1.44 crore

Net profit of Combat Drugs remain constant at Rs 0.08 crore in the quarter ended June 2019 and also during the previous quarter ended June 2018. Sales declined 70.37% to Rs 1.44 crore in the quarter ended June 2019 as against Rs 4.86 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales1.444.86 -70 OPM %7.641.65 -PBDT0.110.08 38 PBT0.110.08 38 NP0.080.08 0

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, August 13 2019. 15:50 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU